Webinar
This is a promotional email intended for Healthcare Professionals in the UK sent on behalf of Takeda. The webinar is initiated and funded by Takeda UK Ltd and Takeda Medicines will be discussed. Prescribing information and adverse event reporting can be found by clicking on the button at the bottom of this email.
Dear Dammy,
Climate change and globalisation are transforming the epidemiology of infectious diseases, with mosquito-borne illnesses emerging as an expanding public health challenge.
We invite you to join C+D and Takeda UK on Thursday, 28 May, 2026 at 2pm BST. This interactive session will guide you in understanding the changing epidemiology of dengue and its emergence in new regions and the implications of shifting disease risk for travel health advice and patient counselling.
In this session you will learn:
- How climate change and globalisation are influencing the geographic distribution of mosquito vectors and mosquito-borne diseases
- The limitations of historic risk maps and traditional epidemiological assumptions in contemporary public health practice
- The evolving role of pharmacists in supporting disease prevention and public health education
- How to integrate emerging epidemiological trends into professional practice and patient-facing guidance
The session will conclude with a live Q&A, ensuring your most pressing queries are answered directly.
Join us to stay ahead of the curve, build your expertise, and feel empowered in your vital role as a pharmacist supporting travel health. Register today!
Qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. The use of Qdenga should be in accordance with official recommendations.[1-3]
1. Qdenga™ Summary of Product Characteristics
2. World Health Organization: Vaccines and immunization: Dengue. Available at https://www.who.int/news-room/questions-and-answers/item/dengue-vaccines (Accessed April 2026)
3. UK Health Security Agency. (2024, October). Immunisation against infectious disease: The green book, chapter 15a – Dengue. TravelHealthPro. Available at: https://travelhealthpro.org.uk/media_lib/mlib-uploads/full/the-green-book-chapter-15a-dengue-october-2024.pdf. [accessed April 2026]
Qdenga® Updates for Pharmacists: Mosquito Borne Diseases in the Context of Climate Change & Globalisation Webinar
DATE: Thursday, 28 May, 2026
TIME: 2pm BST
This is intended for Healthcare Professionals in the UK only.
MEET THE SPEAKERS
Nana Ofori-Atta
Clinical and Custom Content Editor, C+D
Nana Ofori-Atta, a seasoned pharmacist, brings a wealth of expertise as the Clinical and Custom Content Editor at C+D. Since joining in 2022, Nana has played a pivotal role in crafting insightful clinical content and developing our learning content. With a keen grasp of pharmaceutical practices, he ensures content meets the highest standards of accuracy and relevance. Nana’s dedication to empowering pharmacists with up-to-date information makes him an invaluable asset to the C+D team.
Professor Derek Evans
Evans Healthcare Consultancy Ltd.- Director and Owner
Derek is a travel medicine practitioner and independent prescriber with a background of over 30 years in clinical practice, education and practice-based research. He has worked closely with travel health providers including national companies, private practices and education providers across the pharmaceutical industry.
Don’t want to receive these emails? No problem, simply click on the Unsubscribe link below.
By accessing this content, you are permitting CD Partnered Content or a third party to contact you regarding the content (by phone or email).
© 2026 Marketing Masters Hub. All rights reserved.